SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-23-010401 to Garden Stage Ltd (GSIW) (CIK 0001954269) (GSIW)

Garden Stage Ltd (GSIW) (CIK 0001954269)
Date: Sept. 20, 2023 · CIK: 0001954269 · Accession: 0000000000-23-010401

AI Filing Summary & Sentiment

File numbers found in text: 333-273053

Date
September 20, 2023
Author
Office of Finance
Form
UPLOAD
Company
Garden Stage Ltd (GSIW) (CIK 0001954269)

Letter

United States securities and exchange commission logo September 20, 2023 Sze Ho Chan Chief Executive Officer Garden Stage Limited Room 201, 2/F, China Insurance Group Building 141 Des Voeux Road Central Central, Hong Kong Re:Garden Stage Limited Amendment No. 1 to Registration Statement on Form F-1 Filed September 5, 2023 File No. 333-273053 Dear Sze Ho Chan: We have reviewed your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to these comments, we may have additional comments. Unless we note otherwise, our references to prior comments are to comments in our July 27, 2023 letter. Amendment No. 1 to Registration Statement on Form F-1 Risk Factors We may become subject to a variety of PRC laws and other obligations, page 27 1.We note your response to our prior comment 2 and your revised disclosure. Please also revise your disclosure on page 29 that continues to state that “the Trial Measures have not come into effect as of the date of this prospectus.” Dilution, page 65 2.We note your response to our prior comment 5 and related revisions on pages 65 and 66. Please tell us and revise your disclosure to include an explanation for why you add back

FirstName LastNameSze Ho Chan Comapany NameGarden Stage Limited September 20, 2023 Page 2 FirstName LastName Sze Ho Chan Garden Stage Limited September 20, 2023 Page 2 the deferred IPO costs in the pro forma as adjusted net tangible book value as of March 31, 2023. You may contact Lory Empie at (202) 551-3714 or Robert Klein at (202) 551-3847 if you have questions regarding comments on the financial statements and related matters. Please contact Robert Arzonetti at (202) 551-8819 or Tonya Aldave at (202) 551-3601 with any other questions. Sincerely, Division of Corporation Finance Office of Finance cc: Yarona L. Yieh, Esq.

Show Raw Text
United States securities and exchange commission logo
September 20, 2023
Sze Ho Chan
Chief Executive Officer
Garden Stage Limited
Room 201, 2/F, China Insurance Group Building
141 Des Voeux Road Central
Central, Hong Kong
Re:Garden Stage Limited
Amendment No. 1 to Registration Statement on Form F-1
Filed September 5, 2023
File No. 333-273053
Dear Sze Ho Chan:
            We have reviewed your amended registration statement and have the following
comments.  In some of our comments, we may ask you to provide us with information so we
may better understand your disclosure.
            Please respond to this letter by amending your registration statement and providing the
requested information.  If you do not believe our comments apply to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
            After reviewing any amendment to your registration statement and the information you
provide in response to these comments, we may have additional comments.  Unless we note
otherwise, our references to prior comments are to comments in our July 27, 2023 letter.
Amendment No. 1 to Registration Statement on Form F-1
Risk Factors
We may become subject to a variety of PRC laws and other obligations, page 27
1.We note your response to our prior comment 2 and your revised disclosure. Please also
revise your disclosure on page 29 that continues to state that “the Trial Measures have not
come into effect as of the date of this prospectus.”
Dilution, page 65
2.We note your response to our prior comment 5 and related revisions on pages 65 and 66.
Please tell us and revise your disclosure to include an explanation for why you add back

 FirstName LastNameSze Ho Chan
 Comapany NameGarden Stage Limited
 September 20, 2023 Page 2
 FirstName LastName
Sze Ho Chan
Garden Stage Limited
September 20, 2023
Page 2
the deferred IPO costs in the pro forma as adjusted net tangible book value as of March
31, 2023.
            You may contact Lory Empie at (202) 551-3714 or Robert Klein at (202) 551-3847 if you
have questions regarding comments on the financial statements and related matters.  Please
contact Robert Arzonetti at (202) 551-8819 or Tonya Aldave at (202) 551-3601 with any other
questions.
Sincerely,
Division of Corporation Finance
Office of Finance
cc:       Yarona L. Yieh, Esq.